Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Young Oluokun"'
Autor:
Patrick Dakum, Juliet Ajav-Nyior, Timothy A Attah, Gbenga A Kayode, Asabe Gomwalk, Helen Omuh, Halima Ibrahim, Mercy Omozuafoh, Abimiku Alash'le, Charles Mensah, Young Oluokun, Franca Akolawole
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250345 (2021)
ObjectivesThis study evaluates the effect of Community Anti-retroviral Groups on Immunologic, Virologic and clinical outcomes of stable Antiretroviral Therapy patients in Nigeria.MethodA cohort of 251 eligible adults (≥18 years) on first-line ART f
Externí odkaz:
https://doaj.org/article/86da3f869e6a4a6fb04455fc8da7cadb
Autor:
Tongdiyen L Jasper, MD, Iheanyichukwu Onwubiko, MD, Imoiboho Williams, BPharm, Oriaku Ofem, MD, Uteng Wilson, MD, Hyacinth I Nnaemeka, BPharm, Iboro E Nta, MD, Young Oluokun, MD, Sunny Phillips, MD, Patrick Dakum, MD
Publikováno v:
The Lancet Global Health, Vol 7, Iss , Pp S20- (2019)
Background: Isoniazid preventive therapy (IPT) significantly reduces the incidence of active tuberculosis in people living with HIV. However, despite high tuberculosis morbidity and mortality in people living with HIV, uptake of IPT remains grossly s
Externí odkaz:
https://doaj.org/article/f1d3bdca0697431dabe0f7de9061134e
Autor:
Gbenga A. Kayode, Young Oluokun, Halima Ibrahim, Helen Omuh, Charles Mensah, Franca Akolawole, Patrick Dakum, Mercy Omozuafoh, Timothy A Attah, Abimiku Alash'le, Juliet Ajav-Nyior, Asabe Gomwalk
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0250345 (2021)
PLoS ONE
PLoS ONE
Objectives This study evaluates the effect of Community Anti-retroviral Groups on Immunologic, Virologic and clinical outcomes of stable Antiretroviral Therapy patients in Nigeria. Method A cohort of 251 eligible adults (≥18 years) on first-line AR
Autor:
Young Oluokun, Hyacinth I Nnaemeka, Sunny Phillips, Oriaku Ofem, Patrick Dakum, Imoiboho Williams, Uteng Wilson, Tongdiyen L Jasper, Iheanyichukwu Onwubiko, Iboro Nta
Publikováno v:
The Lancet Global Health, Vol 7, Iss, Pp S20-(2019)
Background Isoniazid preventive therapy (IPT) significantly reduces the incidence of active tuberculosis in people living with HIV. However, despite high tuberculosis morbidity and mortality in people living with HIV, uptake of IPT remains grossly su
Autor:
Dakum, Patrick1,2 (AUTHOR), Ajav-Nyior, Juliet1 (AUTHOR), Attah, Timothy A.1 (AUTHOR) attah_adejoh@yahoo.com, Kayode, Gbenga A.1,3 (AUTHOR), Gomwalk, Asabe1 (AUTHOR), Omuh, Helen1 (AUTHOR), Ibrahim, Halima1 (AUTHOR), Omozuafoh, Mercy1 (AUTHOR), Alash'le, Abimiku2,3 (AUTHOR), Mensah, Charles1 (AUTHOR), Oluokun, Young1 (AUTHOR), Akolawole, Franca1 (AUTHOR)
Publikováno v:
PLoS ONE. 4/26/2021, Vol. 16 Issue 4, p1-14. 14p.